Mycogen Corp., which develops and markets biopesticides, hascompleted an offering of 2 million shares of common stock at$14.50 per share. Of those shares, 1,272,092 were offered bythe San Diego company, raising $18.4 million beforeunderwriting fees.
The remaining 727,908 shares were sold by sellingstockholders who received their shares in connection withMycogenLs acquisition of Soilserv, a crop-protection service, inAugust. After the offering, Mycogen has 14 million sharesoutstanding.
Underwriters Morgan Stanley & Co. Inc. and Piper, Jaffray &Hopwood Inc. have a 300,000-share overallotment option.Mycogen
(c) 1997 American Health Consultants. All rights reserved.